Newsletter

​After the resumption of short selling, 62% of the total volume was traded through foreign securities companies.

Investigation into Yoon Chang-hyun’s People’s Strength Councilor’s Office… Focus on Samsung Electronics, HMM, Celltrion Healthcare, Seegene, etc.

[사진=게티이미지뱅크]

Since short selling resumed in the domestic stock market in May, more than 60% of the total volume has been traded through foreign securities companies.

According to the Office of the People’s Strength Councilor Yoon Chang-hyeon on the 1st, it was revealed that from May to October 18, the amount of short selling by the top four foreign securities companies this year was 41,177.5 billion won. This is equivalent to 62% of all short selling transactions in Korea.

Among them, the amount of foreign securities companies with the largest number of short selling transactions was 24,213.9 billion won, accounting for 36.7% of the total.

In the meantime, individual investors have been asked to disclose the size of short selling transactions by securities companies, but this is the first time that the actual transaction amount has been released.

In the KOSDAQ market as well as the KOSPI, the top securities companies in short selling were all foreign-owned. In the stock market, the amount of short selling by foreign A securities company recorded 18.886.9 billion won, followed by foreign B securities company with 5,372.6 billion won. The top five securities companies in short selling in the stock market are all foreign securities companies.

In the KOSDAQ market, foreign securities firms ranked first to third. In the case of Company A, the amount of short selling on the KOSDAQ market was 5,327.1 billion won, while B Securities, in second place, recorded 1.54 trillion won.

Foreign securities companies’ short selling transactions were concentrated on a few stocks. In the stock market, Samsung Electronics, HMM, LG Electronics, Kakao, and SK Hynix were intensively short-sold, and in the KOSDAQ market, Celltrion Healthcare, EcoproBM, Seegene, and Celltrion Pharmaceuticals were short-sold.

© ‘Global Economic Daily in 5 Languages’ Aju Economic Daily. Unauthorized reproduction and redistribution prohibited

.